McGill University
- Country
- šØš¦Canada
- Ownership
- Private
- Established
- 1821-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mcgill.ca
Clinical Trials
247
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (220 trials with phase data)ā¢ Click on a phase to view related trials
Evaluating Knowledge Mobilization Sustainability Approaches
- Conditions
- StressCopingWell-beingMindfulnessBehaviour ChangeAdherenceDigital Intervention
- First Posted Date
- 2025-11-21
- Last Posted Date
- 2025-11-21
- Lead Sponsor
- McGill University
- Target Recruit Count
- 331
- Registration Number
- NCT07242378
- Locations
- šØš¦
McGill University, Montreal, Quebec, Canada
Virtual Reality for Post-Stroke Gait Rehabilitation
- Conditions
- Stroke
- First Posted Date
- 2025-10-01
- Last Posted Date
- 2025-10-01
- Lead Sponsor
- McGill University
- Target Recruit Count
- 40
- Registration Number
- NCT07201974
- Locations
- šØš¦
Jewish Rehabilitation Hospital, Laval, Quebec, Canada
Feasibility of Real-Time Visual Feedback in Augmented Reality to Reduce Gait Asymmetry Post-Stroke
- Conditions
- Stroke
- First Posted Date
- 2025-09-17
- Last Posted Date
- 2025-09-22
- Lead Sponsor
- McGill University
- Target Recruit Count
- 20
- Registration Number
- NCT07178535
- Locations
- šØš¦
Jewish Rehabilitation Hospital - CISSS Laval, Laval, Quebec, Canada
Effects of Omeprazole Ingestion on Postprandial Amino Acid Concentrations in Response to a Mixed Meal
- Conditions
- Digestive HealthGastrointestinal Health
- Interventions
- Other: Placebo
- First Posted Date
- 2025-08-26
- Last Posted Date
- 2025-11-21
- Lead Sponsor
- McGill University
- Target Recruit Count
- 4
- Registration Number
- NCT07142486
- Locations
- šØš¦
McGill University, Montreal, Quebec, Canada
Effect of Music on Surgical Performance During Artificial Intelligence-Based Simulation Training
- Conditions
- Surgical Education
- First Posted Date
- 2025-08-08
- Last Posted Date
- 2025-08-22
- Lead Sponsor
- McGill University
- Target Recruit Count
- 40
- Registration Number
- NCT07111481
- Locations
- šØš¦
Neurosurgical Simulation and Artificial Intelligence Learning Centre, Montreal, Quebec, Canada
- Prev
- 1
- 2
- 3
- 4
- 5
- 49
- Next
News
Epitopea's CryptoMap Platform Identifies Novel Immunotherapy Targets in Melanoma and NSCLC
Epitopea's CryptoMap platform identified 589 non-redundant tumor antigens in cutaneous melanoma and NSCLC, with only 1% derived from mutated sequences.
Novel Nucleus Pulposus Allograft Shows Promise for Chronic Back Pain Treatment
Clinical trials of VIA Disc NP, a minimally invasive treatment using donor nucleus pulposus tissue, demonstrated significant reduction in chronic back pain from 7.1 to 3.8 on a 10-point scale over 12 months.
Lecanemab's Effectiveness for Alzheimer's May Be Significantly Lower in Female Patients, Study Suggests
ā¢ Recent analysis of lecanemab (Leqembi) clinical trial data reveals a 31% difference in drug effectiveness between male and female Alzheimer's patients, with men showing a 43% slowing of cognitive decline compared to just 12% in women. ā¢ Researchers from McGill University conducted 10,000 simulated trials based on Phase 3 CLARITY AD data, finding the gender disparity occurred randomly in only 12 simulations, suggesting the difference is statistically meaningful. ā¢ The findings have significant implications for clinical practice as two-thirds of Alzheimer's patients are female, highlighting the urgent need for sex-specific considerations in both drug development and treatment decisions.
Study Reveals 16% of Phase 2 Cancer Trial Patients Receive Eventually FDA-Approved Drugs
A comprehensive analysis of 2,730 phase 2 cancer trials shows that one in six patients receives treatments that ultimately gain FDA approval, providing important insights for clinical trial recruitment.